Open AccessResponse to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the scientific substantiation of a health claim related to an equimolar mixture of the CLA isomers c 9, t 11 and t 10, c 12 (marketed as Clarinol® and Tonalin®) and “contributes to a reduction in body fat mass” pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Publication year - 2015
Publication title -
efsa supporting publications
Language(s) - English
Resource type - Journals
ISSN - 2397-8325
DOI - 10.2903/sp.efsa.2015.en-858
Subject(s) - food safety , health claims on food labels , environmental health , european commission , food science , political science , business , european union , medicine , chemistry , economic policy